News
Deciphera Presents Preclinical Data from DCC-3116 Program at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics ...
Hosted on MSN15d
DCC plc Advances £100 Million Share Buyback Program - MSN
This move is part of a larger buyback program valued at up to £100 million, which is set to run until the end of September 2025. The repurchased shares will be cancelled, reducing the total ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback